Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
5'UTR mutations of ENG cause hereditary hemorrhagic telangiectasia.
|
22192717 |
2011 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
Umbilical vein and placental vessels from newborns with hereditary haemorrhagic telangiectasia type 1 genotype are normal despite reduced expression of endoglin.
|
14972453 |
2004 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
In four patients, the deletion includes endoglin (ENG), causative of hereditary hemorrhagic telangiectasia.
|
22722545 |
2012 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We report an HHT patient with allelic dropout that on routine sequence analysis for a known mutation in the family (c.817-3T>G in ENG) initially seemed to be homozygous for the mutation.
|
23046070 |
2012 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
A novel endoglin mutation in hereditary hemorrhagic telangiectasia type 1: a case report.
|
25760803 |
2015 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
Biomarker
|
disease |
BEFREE |
Endoglin-mediated vascular remodeling: mechanisms underlying hereditary hemorrhagic telangiectasia.
|
18206806 |
2008 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Defective TGF-beta signaling in endothelial cells attributable to mutations in endoglin or the type I receptor ALK-1 leads to hereditary hemorrhagic telangiectasia, whereas defective BMP signaling attributable to mutations in the BMP receptor II has been associated with development of primary pulmonary hypertension.
|
16675726 |
2006 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2.
|
10767348 |
2000 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia.
|
9245986 |
1997 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Heterozygous mutations in the endoglin gene (ENG) cause hereditary hemorrhagic telangiectasia type 1, a vascular disease that presents with nasal and gastrointestinal bleeding, skin and mucosa telangiectases, and arteriovenous malformations in internal organs.
|
31540324 |
2019 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia.
|
15718503 |
2005 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Characterization of pulmonary arteriovenous malformations in ACVRL1 versus ENG mutation carriers in hereditary hemorrhagic telangiectasia.
|
29048420 |
2018 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
ENG c.-58G > A may therefore be a pathogenic HHT mutation leading to haploinsufficiency of Endoglin and HHT symptoms.
|
28231770 |
2017 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
Biomarker
|
disease |
BEFREE |
Endoglin expression in HHT1 or HHT2 activated monocytes and blood outgrowth endothelial cells (BOECs) from older patients was well below the theoretical 50% level expected from the HHT1 haploinsufficiency model, suggesting that the pathogenic endoglin haploinsufficiency leading to the HHT phenotype is age-dependent.
|
16470589 |
2006 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Copy number variations in endoglin locus: mapping of large deletions in Spanish families with hereditary hemorrhagic telangiectasia type 1.
|
24267784 |
2013 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The endothelial receptor endoglin is involved in inflammation through integrin-mediated leukocyte adhesion and transmigration; and heterozygous mutations in the endoglin gene cause hereditary hemorrhagic telangiectasia type 1.
|
29080903 |
2018 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
Biomarker
|
disease |
BEFREE |
Endoglin-deficient mice, a unique model to study hereditary hemorrhagic telangiectasia.
|
11343967 |
2000 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Patients with hereditary hemorrhagic telangiectasia genotype ALK-1 (HHT2-ALK-1) with nonsense mutation demonstrated tendentially higher health-related quality of life (HR-QOL) scores than patients with HHT with genotype ENG (HHT1-ENG) with missense mutation.
|
18855162 |
2009 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
Biomarker
|
disease |
BEFREE |
Endoplasmic reticulum quality control is involved in the mechanism of endoglin-mediated hereditary haemorrhagic telangiectasia.
|
22022569 |
2011 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Characterization of 17 novel endoglin mutations associated with hereditary hemorrhagic telangiectasia.
|
12673790 |
2003 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Endoglin gene mutations and polymorphisms in Italian patients with hereditary haemorrhagic telangiectasia.
|
12786761 |
2003 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Endoglin (CD105) is a membrane glycoprotein that is mutated in hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease) and shows increased expression in proliferating endothelial cells during angiogenesis.
|
12947156 |
2003 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
Biomarker
|
disease |
BEFREE |
Since the landmark discovery that bone morphogenetic protein receptor type II (BMPR2) mutations cause the majority of cases of familial PAH, investigators have discovered mutations in genes that cause PAH in families without BMPR2 mutations, including the type I receptor ACVRL1 and the type III receptor ENG (both associated with hereditary hemorrhagic telangiectasia), caveolin-1 (CAV1), and a gene (KCNK3) encoding a two-pore potassium channel.
|
25159282 |
2014 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Mosaic ACVRL1 and ENG mutations in hereditary haemorrhagic telangiectasia patients.
|
21378382 |
2011 |
Hereditary hemorrhagic telangiectasia
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Our questionnaire based study provides evidence that the HHT phenotype caused by mutations in endoglin (HHT1) is distinct from, and more severe than, HHT caused by mutations in ALK1 (HHT2).
|
12920067 |
2003 |